The Effect of curcumin on oxidative indices, inflammatory factors and Sequential Organ Failure Assessment Score in patients with systemic inflammatory response syndrome
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
Introduction Sepsis is a severe reaction and excessive immune response to infection, which can lead to tissue damage, organ dysfunction, and death. This study aimed to investigate the protective effect of curcumin on inflammatory factors and clinical outcomes in patients with sepsis. Methods This randomized clinical trial was conducted on 40 patients with sepsis aged 18–55 years, who received 160?mg of nano curcumin supplement (two capsules 80?mg) or placebo (two capsules of placebo) via a nasogastric tube for 10 days. Sequential organ failure assessment (SOFA) was evaluated on days 1 and 10. Serum levels of inflammatory factors of procalcitonin (PCT), Interleukin- 6 (IL-6), tumor necrosis factor-alpha, (TNF-a),and high-sensitive C-reactive protein (hs-CRP) were measured before the beginning of the intervention and on days 5 and 10. Length of hospital stay, mortality rate, and mechanical ventilation duration was compared between groups. Results Serum levels of PCT (p?=?0.002), IL-6 (p?=?0.012), and TNF-a (p?=?0.026) in the nano curcumin group on day 10 were significantly lower than in the placebo group. The duration of mechanical ventilation in the nano curcumin group was remarkably (p?=?0.038) lower than in the placebo group. Also, the SOFA score significantly (p?=?0.005) decreased in the intervention group compared to the placebo group. No significant difference was observed in the mean serum levels of hs-CRP, duration of the intensive care unit stay, and mortality rates between the study groups. Conclusions Our study indicated that nano curcumin could decrease the levels of inflammatory factors, duration of mechanical ventilation, and organ failure in critically ill patients.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years(—)
- 性别
- All
入选标准
- •Critically ill ICU patients with APACHE II score of 15-30;
- •Positive SIRS;
- •Aged over 18 and under the age of 60 years;
- •Hospitalization at least 10 days in ICU;
- •Recipients of enteral nutrition formula
排除标准
- •Parenteral feeding;
- •Intolerance to enteral feeding and gavage solution;
- •Patient is waiting for death in the 24 future hourse;
- •HIV positive patient;
- •pregnant and lactating women;
- •Mellitus diabetes;
- •Short bowel syndrome;
- •Pancreatitis;
- •Immune disorders
